Recently, a study demonstrated that fibroblast growth factor receptor 2 (FGFR-2) interacts with progesterone receptor (PR) and STAT5 in hormone receptor-positive T47D breast cancer cells and in breast cancer patient samples. This evidence concerns the gene PGR and breast carcinoma.